Aldeyra Therapeutics Inc (STU:137)
€ 5.196 0.038 (0.74%) Market Cap: 265.33 Mil Enterprise Value: 167.12 Mil PE Ratio: 0 PB Ratio: 2.88 GF Score: 38/100

Q2 2022 Aldeyra Therapeutics Inc Earnings Call Transcript

Aug 05, 2022 / 12:00PM GMT
Release Date Price: €6.86 (+18.92%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Second Quarter 2022 Financial Results Conference Call. (Operator Instructions)

I would now like to hand over the conference to the company's Interim Chief Financial Officer, Mr. Bruce Greenberg. Please go ahead, sir.

Bruce Greenberg
Aldeyra Therapeutics, Inc. - VP of Finance, Interim CFO & Treasurer

Good morning, everyone. With me today is Dr. Todd Brady, our President and Chief Executive Officer. This morning, we issued a press release reporting our financial results for the quarter ended June 30, 2022, in recent corporate highlights. A copy of the press release is available on the Investor & Media section of our website at www.aldeyra.com.

Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include, but are not limited to, statements regarding submission of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot